Emollients

to prevent neonatal infection

Prevention
Prevention
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Emollients

     

    Condition

    The skin of premature neonates is only a fraction the thickness of a full term infant which makes it a poor barrier to the environment.  The immature skin does not retain water as well as mature skin and is more vulnerable to wounds, both of which are determinants of neonatal infection. The skin provides a vector for hospital acquired and other infections which cause more than 900,000 deaths per year, worldwide.

    Mechanism of Action

    Emollient ointments are commonly used to treat dry skin in all populations as they help the body retain moisture. Since preterm neonatal skin is particularly fragile and an inferior barrier to pathogens than fully developed skin, a periodic treatment of emollient over most of an infant's body is sometimes used to provide an additional barrier and to help the skin develop.

    Emollients have been used to improve the condition of neonatal skin for centuries and recent research has explored the effects and potential of this practice. Most promisingly, Aquaphor and sunflower seed oil have been found to decrease the chance of mortality notably by decreasing the chance of hospital acquired infection. The researchers found that a twice daily whole body treatment of aquaphor for two weeks after a preterm birth decreased mortality by 32%.

    Unfortunately, recent research has also found damaging effects of some emollients in  some circumstances. The most commonly used traditional emollient for neonates, mustard seed oil, has been found to have a generally damaging effect on the skin's function as a barrier. Even Aquaphor, a highly developed barrier, is not always helpful. A multicenter trial in the United States found it to actually increase the incidence of infection among premature neonates of birth-weight less than 1kg.


    Current use in High-Resource Settings

    Emollients are not used as a generalized skin treatment for neonates in high-resource settings. Instead, moisturizers of various kinds are used to treat particular skin conditions and wounds.

     

    Current use in Low-Resource Settings

    The most common use of emollients in low-resource settings is mustard oil in southern Asia. However, it may be toxic to keratinocytes of the skin. In south Asia and elsewhere, a variety of other emollients, including sunflower seed oil, are used by hospitals and traditional birth attendants. Furthermore, the research and WHO report have renewed interest in the medical use of whole body emollient treatment of preterm neonates, though it is not obvious how widespread adoption has been.

    REPRESENTATIVE PRODUCTS

    MAKE
    MODEL
    PRICE
    TECH
    STATUS
    NOTES

    Eucerin

    Aquaphor Ointment
    $5/oz
    Marketed
    No preservatives

    Eucerin

    Eucerin Cream
    $1.45/oz
    Marketed
    Less studied in low resource settings

    Generic

    Sunflower Seed Oil
    $1.00/oz
    Marketed
    Produced in country

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    TECHNOLOGY CHARACTERISTICS

    OPERATIONAL PARAMETERS

    Sunflower Seed Oil

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Nurse
    <30 min
    10 min

    Skill and care is required to maintain a clean treatment and avoid presenting the neonate with pathogens when doing the emollient massage.

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    None
    Trash
    None
    None

    COST

    Device Cost (approximate)
    Cost/course (approximate)
    $1.00/oz

    Cost is for sunflower seed oil.

    OTHER

    Portability
    Regulatory
    Efficacy
    ~200g/course
    26% reduction in mortality among low birthweight neonates at a hospital in Bangladesh.

Sources: Amnesty LeFevre a, Samuel D Shillcutt a, Samir K Saha b, ASM Nawshad Uddin Ahmed c, Saifuddin Ahmed d, MAK Azad Chowdhury e, Paul A Law f, Robert Black a, Mathuram Santosham a & Gary L Darmstadt a. The Effect of Prophylactic Ointment Therapy on Nosocomial Sepsis Rates and Skin Integrity in Infants With Birth Weights of 501 to 1000 g William H. Edwards, MD*, Jeanette M. Conner, MS, PhD‡, Roger F. Soll, MD§, for the Vermont Oxford Network Neonatal Skin Care Study Group. Seliem W, Bhutta ZA, Soll R, McGuire W. Topical emollient therapy for preventing infection in preterm infants in low- or middle-income countries (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006666. DOI: 10.1002/14651858.CD006666.. Conner JM, Soll R, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001150. DOI: 10.1002/14651858.CD001150.pub2. Neonatal sepsis: an international perspective. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT. Source International Perinatal Care Unit, Centre for International Child Health, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. s.vergnano@ich.ucl.ac.uk.